finance.yahoo.com

MiniMed Flex Pump Gains Share as MiniMed Raises Guidance

Medtronic logoMedtronic
Sig3.35Sen+6.65Env0.00Soc+3.85Gov0.00

MiniMed’s Flex insulin pump is accelerating sales after late-June shipments, with US revenue up 13.1% and new pump sales rising more than 20% year over year as conversions from rival systems double. Western Europe demand is improving as Simplera sensor output triples, lifting UK pump sales 50% and France 20%. MiniMed also filed a 510(k) for its Fit patch pump and saw Vivera trial results with 74% time in range; full-year organic growth guidance rises to about 10.5%, despite $111M separation and standup costs.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro